Peritoneal dialysis-related peritonitis caused by gram-negative organisms: ten-years experience in a single center

References

• Ballinger AE, Palmer SC, Wiggins KJ, et al. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst Rev. 2014;26(4):CD005284.
   Google Scholar
• McGuire AL, Carson CF, Inglis TJ, et al. Effects of a statewide protocol for the management of peritoneal dialysis-related peritonitis on microbial profiles and antimicrobial susceptibilities: a retrospective five-year review. Perit Dial Int. 2015;35(7):722–728.
   PubMed Web of Science ®Google Scholar
• Barretti P, Pereira D, Brasil Maria A, et al. Evolution of gram-negative bacilli susceptibility in peritoneal dialysis-related peritonitis in Brazil: a single center’s experience over nine years. Perit Dial Int. 2009;29(2):230–233.
   PubMed Web of Science ®Google Scholar
• Gadola L, Poggi C, Dominguez P, et al. Risk factors and prevention of peritoneal dialysis-related peritonitis. Perit Dial Int. 2019;39(2):119–125.
   PubMed Web of Science ®Google Scholar
• Feng X, Yang X, Yi C, et al. Escherichia coli Peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center. Perit Dial Int. 2014;34(3):308–316.
   PubMed Web of Science ®Google Scholar
• Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508.
   PubMed Web of Science ®Google Scholar
• Perl J, Fuller DS, Bieber BA, et al. Peritoneal dialysis-related infection rates and outcomes: results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis. 2020;76(1):42–53.
   PubMed Web of Science ®Google Scholar
• Hwang TY, Kim MG, Oh SW, et al. Pathogens of peritoneal dialysis peritonitis: trends from a single-center experience over 15 years. Kidney Res Clin Pract. 2020;39(2):221–227.
   PubMed Web of Science ®Google Scholar
• Huang ST, Chuang YW, Cheng CH, et al. Evolution of microbiological trends and treatment outcomes in peritoneal dialysis-related peritonitis. Clin Nephrol. 2011;75(05):416–425.
   PubMedGoogle Scholar
• Yang X, Yu X. Clinical prevention and treatment strategy of gram-negative bacterial peritonitis. J Nephrol Dialy Transplant. 2008;6(17):534–535.
   Google Scholar
• Cho Y, Htay H, Johnson DW. Center effects and peritoneal dialysis-related peritonitis. Nephrol Dial Transplant. 2017;32(6):913–915.
   PubMed Web of Science ®Google Scholar
• Hautem N, Morelle J, Sow A, et al. The NLRP3 inflammasome has a critical role in peritoneal dialysis-related peritonitis. J Am Soc Nephrol. 2017;28(7):2038–2052.
   PubMed Web of Science ®Google Scholar
• Yang C-Y, Chen T-W, Lin Y-P, et al. Determinants of catheter loss following continuous ambulatory peritoneal dialysis peritonitis. Perit Dial Int. 2008;28(4):361–370.
   PubMed Web of Science ®Google Scholar
• Ozisik1 L, Nurhan Ozdemir F, Tanriover MD, et al. The changing trends of peritoneal dialysis related peritonitis and novel risk factors. Ren Fail. 2015;37(6):1027–1032.
   PubMed Web of Science ®Google Scholar
• Wang H-H, Huang C-H, Kuo M-C, et al. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: a ten-year single-center study in Taiwan. J Microbiol Immunol Infect. 2019;52(5):752–759.
   PubMedGoogle Scholar
• Htay Htay Y, Cho EM, Pascoe , et al. Center effects and peritoneal dialysis peritonitis outcomes: analysis of a national registry. Am J Kidney Dis. 2018;71(6):814–821.
   PubMed Web of Science ®Google Scholar
• Szeto C-C, Li PK-T. Peritoneal dialysis-associated peritonitis. Clin J Am Soc Nephrol. 2019;14(7):1100–1105.
   PubMed Web of Science ®Google Scholar
• Ferri M, Ranucci E, Romagnoli P, et al. Antimicrobial resistance: a global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017;57(13):2857–2876.
   PubMed Web of Science ®Google Scholar
• Kitterer D, Latus J, Pöhlmann C, et al. Microbiological surveillance of peritoneal dialysis associated peritonitis: antimicrobial susceptibility profiles of a referral center in Germany over 32 years. PLoS One. 2015;10(9):e0135969.
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Munoz–Price LS. The new beta-lactamases. N Engl J Med. 2005;352(4):380–391.
   PubMed Web of Science ®Google Scholar
• Leung CB, Szeto CC, Chow KM, et al. Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis – a randomized controlled trial. Perit Dial Int. 2004;24(5):440–446.
   PubMed Web of Science ®Google Scholar
• D'Souza AL. Ageing and the gut. Postgrad Med J. 2007;83(975):44–53.
   PubMed Web of Science ®Google Scholar
• Zurowska A, Feneberg R, Warady BA, et al. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am J Kidney Dis. 2008;51(3):455–462.
   PubMed Web of Science ®Google Scholar
• Krishnan M, Thodis E, Ikonomopoulos D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2002;22(5):573–581.
   PubMed Web of Science ®Google Scholar
• Li Y, Gong N, Zhou H, et al. The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: a single-center, observational clinical study. Clin Nephrol. 2019;92(1):44–51.
   PubMed Web of Science ®Google Scholar
• Xu R, Chen Luo YS, et al. Clincal characteristics and outcomes of peritoneal dialysis-related peritonitis with different trends of change in effluent white well count: a longitudinal study. Perit Dial Int. 2013;33(4):436–444.
   PubMed Web of Science ®Google Scholar
• Troidle L, Kliger A, Gorban-Brennan N, et al. Course of C-reactive protein during continuous peritoneal dialysis-associated peritonitis. Nephrology. 2005;10(5):442–445.
   PubMed Web of Science ®Google Scholar
• Wei-Hung L, Chin-Chung T, An-Bang W, et al. Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Klebsiella pneumoniae in Southern Taiwan. J Microbiol Immunol Infect. 2015;48(3):276–283.
   PubMedGoogle Scholar
• Li PH, Cheng VCC, Yip T, et al. Epidemiology and clinical characteristics of Acinetobacter peritoneal dialysis-related peritonitis in Hong Kong – with a perspective on multi-drug and carbapenem resistance. Perit Dial Int. 2017;37(2):177–182.
   PubMed Web of Science ®Google Scholar
• Dias RCB, Vieira MA, Moro AC, et al. Characterization of Escherichia coli obtained from patients undergoing peritoneal dialysis and diagnosed with peritonitis in a Brazilian centre. J Med Microbiol. 2019;68(9):1330–1340.
   PubMed Web of Science ®Google Scholar
• Yip T, Tse KC, Lam MF, et al. Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients. Perit Dial Int. 2006;26(2):191–197.
   PubMed Web of Science ®Google Scholar
• Malloy AM, Campos JM. Extended-spectrum beta-lactamases: a brief clinical update. Pediatr Infect Dis J. 2011;30(12):1092–1093.
   PubMed Web of Science ®Google Scholar